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INVITED CONTRIBUTION
Message from the President
In 1960, the first meeting of the International Society of
Nephrology (ISN) was a major step in the founding of Nephrology
itself. Now, 35 years later the XIIIth Congress of the ISN will take
place next year in Madrid, from 2nd to 6th July. We met in
Jerusalem only last year, but two years later we will meet again in
Madrid. What is the strategy behind this change of pace?
In 1990 then-President Robinson proposed, and the Executive
Committee and Council of the ISN accepted, to have the Con-
gresses of the Society every two years. The objects of this change
were several, and principally reflect a quicker pace and more
prompt response on the part of the Society to world events. Our
intention was not to increase the number of nephrology meetings;
our specific intention was the reverse. The means to this end were
that the Congresses of the ISN would become joint meetings with
supranational (continental) Societies of Nephrology already ac-
tive in the various regions of the world.
In 1997 the meeting will be a World Congress of Nephrology
organized jointly with the Asian-Pacific Society, and hosted by the
Australian and New Zealand Society; in 1999, we will join with the
Sociedad LatinoAmericana de NefrologIa, hosted by the Brazilian
Society in Rio; and in 2001 we will join the American Society of
Nephrology which, though their full Canadian and Mexican
memberships represent North American Nephrology, will be held
in San Francisco.
Although the ISN now sponsors many activities, not the least of
which is our very successful journal Kidney International, together
with fellowship and educational programs in developing countries,
our Congresses have a very special place in our calendar. The
meeting provides a forum for delegates from all parts of the world
to get together and discuss basic and clinical aspects of nephrology
in a single multidisciplinary meeting. In particular, they provide a
unique opportunity for young investigators and clinical nephrolo-
gists from the five continents to meet personally the experts in the
various fields of nephrology.
What of Madrid? Following the very successful Congress in
Jerusalem in 1993, the program of the Madrid meeting has been
organized again by a Program Committee chaired by Dr. Pierre
Ronco of Paris, France, around a series of Themes which will
encompass and link basic work with clinical expressions and
management of disease. The Themes are listed in Table 1, with
the organizing chairmen responsible for each Theme. Each
Theme will consist of State of the Art lectures, many by investi-
gators working outside the field of nephrology, together with
symposia led by world-renowned experts in the various fields.
Ample time has been allowed for discussion. Topics range from
basic science to clinical applications. Free communications and
Poster presentations will link, where relevant, to the appropriate
Theme.
In addition there will be an extensive set of Clinical Symposia,
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Table 1. Scientific program
THEME 1, Renal Ontogeny and Diseases of Renal Development.
Co-organizers P. Ekblom (Uppsala, Sweden)
J.P. Grunfeld (Paris, France)
A 4-day meeting; 4 State-of-the-Art Lectures and 7 Symposia.
Apoptosis and the regulation of cell numbers, Genetics and molecular
events. Genetic diseases of the kidney, including renal cancer. Gene
therapy: the present and the future. The genetics of cancer.
THEME 2. Biology of Channels and Transporters: From Gene to
Disease.
Co-organizers S. Hebert (Boston, USA)
B. Rossier (Lausanne, Switzerland)
A 4-day meeting; 4 State-of-the-Art Lectures and 8 Symposia. Protein
structure and modelling. Regulation of protein trafficking. The complex
nature of CFTR, and chloride channels. Renal eicosanoids. Water,
sodium and urea channels and transporters. Acidification, Potassium
channels.
THEME 3. Pathobiology of the Vessel Wall.
Co-organizers HR. Brady (Boston, USA)
G. Remuzzi (Bergamo, Italy)
A 3-day meeting; 2 State-of-the-Art Lectures and 5 Symposia.
Selectins. Biology of molecules involved in cell-cell interaction. The
pathogenesis of atherosclerosis. Endothelium and hemostasis. Patho-
physiology of the vessel wall in pregnancy.
THEME 4. Hypertension.
Co-organizers C.S. Wilcox (Gainesville, USA)
F. Luft (Erlangen, Germany)
A 4-day meeting; 4 State-of-the-Art Lectures and 7 Symposia.
Clinical spectrum. Genetics. Vasoactive mediators. Nitric oxide, the
kidney and the circulation. Vascular remodelling. New therapeutic
modalities.
THEME 5. Acute Renal Failure.
Co-organizers N. Lameire (Gent, Belgium)
K.L. Skorecki (Toronto, Canada)
A 4-day meeting; 4 State-of-the-Art Lectures and 8 Symposia.
Pathophysiology and clinical aspects. Apoptosis. Role of calcium,
oxygen radicals, heat shock proteins and nitric oxide in ARF. Adhesion
molecules. Growth factors. ARF in liver disease, sepsis and renal
transplantation. Other clinical aspects and controversies.
THEME 6. Progression of Diabetic and Nondiabetic Renal Disease,
Co-organizers B.M. Brenner (Boston, USA)
W.F. Keane (Minneapolis, USA)
A 4-day meeting; 4 State-of-the-Art Lectures and 8 Symposia.
Genetics. Natural history. Hemodynamics. Matrix remodelling. Cellular
mechanisms of injury. Therapeutic interventions.
THEME 7. Glomerular Diseases.
Co-organizers J. Egido (Madrid, Spain)
R.J. Johnson (Seattle, USA)
A 3-day meeting; 2 State-of-the-Art Lectures and 4 Symposia.
Molecular biology and gene transfer. Apoptosis and control of
proliferation and repair. Inflammatory mediators. New therapeutic
approaches.
THEME 8. Transplantation.
Co-organizers R.A. Sheil (Sydney, Australia)
R.A. Koene (Nijmegen, The Netherlands)
A 4-day meeting; 4 State-of-the-Art Lectures and 8 Symposia. Long-
term complications. Immune response. Xenotransplantation. Thera-
peutic interventions. Viral infections.
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Table 2. Clinical symposia
Chair Subject
G. D'Amico (Milan, Italy) Hepatitis C in nephrology
A. Rees (London, UK) Vasculitis: Mechanisms of injury and
management
J. Rodes (Barcelona, Spain) Renal dysfunction in cirrhosis
M. Watson (Edinburgh, UK) Polycystic kidney disease
R. de Zeeuw (Gronigen, The Hyperlipidemia in the renal patient
Netherlands)
R. Matesanz (Madrid, Spain) Organ procurement and sharing
J. Rodicio (Madrid, Spain) Hypertension and the kidney
A.J. Raine (London, UK) Ischemic heart disease and the renal
patient
M. Abramow (Brussels, Pathophysiology of water and
Belgium) sodium homeostasis
R. Bailey (Christchurch, Urinary tract infection revisited
New Zealand)
A. Howie (Birmingham, UK) Focal segmental
glomerulosclerosis
N. Mallick (Manchester, UK) Clinical trials in nephrology
and H. Jacobson (Nashville,
USA)
which will address major problems of clinical nephrology. Some
will link with and compliment the clinical components of the
Themes, while others will be free-standing. These are listed in
Table 2.
For the first time, to reinforce the clinical components of the
Congress, we will run a Continuing Medical Education (CME)
Program throughout the meeting. This will be directed specifically
at nephrologists in training, nephrologists working in single
practice, and nephrologists from developing countries. This sec-
tion of the Program is being directed by Drs. Harry Jacobson and
Nuhad Ismail of Vanderbilt University, USA, who will provide
CME credits where applicable. The provisional outline of the
CME course is given in Table 3.
We are conscious that major meetings become ever more
expensive, and we have tried to keep the costs of attending the
XIIIth Congress of the ISN as low as possible. The registration fee
for members registering early will be only $400 for almost 300
hours of programming over four days, little more than $1 per
hour! In addition there are 36 hours of the CME course. There
will also be a reduced rate of registration of only $250 for
nephrologists in training. The major cost of the program is, of
course, bringing the 330 non-nephrologists whom we have invited
to come and address and interact with us, bringing their ideas to
us from outside our immediate daily contacts. Apart from the
opening ceremony, social events will be self-funding. Hotels of all
standards have been booked, as well as University accommoda-
tion at basic rates so that those from developing countries and
those with limited funds may be able to attend. As for previous
Congresses, the ISN will be awarding 120 Scholarships of $1000 or
more to allow younger nephrologists without adequate funds to
attend the meeting.
Finally, several Satellite meetings and workshops will be held in
conjunction with the Madrid Congress. As in 1993, the Commis-
Table 3. Daily Continuing Medical Education Course, provisional
program [Organizers: H. Jacobson, N. Ismail (Nashville, USA)
Basic Topics in Consultative Nephrology
Session 1. Diagnosis and management of some electrolyte disorders—
acute renal failure
Session 2. Role of renal biopsy in management of renal disease—
treatment of UTIs—pregnancy/renal interactions
Advances in Consultative Nephrology
Session 1. Evaluation and management of renovascular hypertension
and ischemic disease—recent clinical trials in hypertension and
nephrology
Session 2. Specific therapy of causes of nephrotic syndrome—the
vasculitides and their management
Basic Topics in Dialysis
Session 1. Chronic vascular access—medical management of
thrombosis—membranes (biocompatibility issues)— dialysate
composition
Session 2. CAPD: Prevention, diagnosis and management of exit site
infections—prescription of PD—solutions and equipment
Advances in Dialysis
Session 1. Long-term complications of hemodialysis (/32-microglobulin
amyloidosis, acquired cyctic kidney disease, renal osteodystrophy)
Session 2. Malnutrition in CAPD, use of i.p. amino acids—tidal PD—
adequacy of PD—controversies in the care of the CAPD patient
Basic Topics in Transplantation
Session 1. Selection and preparation of donor and recipient—long-
term complications of transplantation, diagnosis and management
Session 2. Diagnosis and treatment of rejection (basis of rejection—
diagnosis of rejection—prevention and treatment of rejection)
Advances in Transplantation
Session 1. New immunosuppressive agents: CyG, rapamycin,
FK506—mycophenolate, brequinar—monoclonal
antibodies—impact of new molecules on clinical renal
transplantation
Session 2, Transplantation immunology—MHC complex—allograft
tolerance—immunology of xenografting
sion on Acute Renal Failure of the ISN will sponsor a meeting in
Barcelona July 9th to 11th organized by Drs. Luis Piera and Juan
Fort, on topics relating to acute renal failure which will compli-
ment and amplify material presented on this Theme in the main
Madrid meeting. In Seville, on July 7th to 11th, Dr. Francisco
Llach is organizing a meeting on renal bone disease. Again in
Barcelona, Drs. Kiyoshi Kurokawa, Barry Brenner and José
Rodicio are to hold a meeting on hypertension, while in
Salamanca Drs. Juan Maclas Nunez and J.M. López-Novoa will
promote a discussion of renal disease and hypertension in the
elderly.
July 1995 will be, we believe, unprecedented in the history of
nephrology. Although the now biennial Congresses of the ISN
represent only one of the many programs of the ISN, they remain
a core to which our many other activities relate. The presence of
nephrologists from almost every country in the world will be the
most important contribution to the success of the Congress. We
hope to see you in Madrid in July 1995.
Luis HERNANDO
President, XIIIth Congress of the ISN
JOHN STEWART CAMERON
President, ISN
